Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)

China flag China · Delayed Price · Currency is CNY
6.41
-0.49 (-7.10%)
Feb 3, 2026, 3:04 PM CST
-5.04%
Market Cap6.59B -18.3%
Revenue (ttm)578.61M -26.0%
Net Income83.77M +1.7%
EPS0.08 -2.5%
Shares Out1.03B
PE Ratio81.02
Forward PEn/a
Dividend0.02 (0.29%)
Ex-Dividend DateJul 4, 2025
Volume80,125,957
Average Volume28,363,979
Open7.68
Previous Close6.90
Day's Range6.26 - 7.68
52-Week Range5.98 - 8.74
Beta0.33
RSI24.54
Earnings DateApr 23, 2026

About Beijing SL Pharmaceutical

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People’s Republic of China and internationally. The company’s finished formulations include temozolomide; arsenic trioxide; lenalidomide capsules; pegylated human granulocyte-stimulating factor injection; human granulocyte-cell stimulating factor injection; recombinant human basic fibroblast growth factor for external use recombinant human basic fibroblast growth factor gel; human interleukin-11; arsen... [Read more]

Sector Healthcare
Founded 1994
Employees 889
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002038
Full Company Profile

Financial Performance

Financial Statements